Biohaven Ltd [NYSE: BHVN] plunged by -$3.84 during the normal trading session on while it closed the day at $15.82.
Biohaven Ltd stock has also loss -21.88% of its value over the past 7 days. However, BHVN stock has declined by -62.14% in the 3 months of the year. Over the past six months meanwhile, it has lost -69.83% and lost -57.64% year-on date.
The market cap for BHVN stock reached $1.62 billion, with 102.10 million shares outstanding and 88.50 million shares in the current float. Compared to the average trading volume of 1.62M shares, BHVN reached a trading volume of 7699604 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Biohaven Ltd [BHVN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BHVN shares is $58.28 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BHVN stock is a recommendation set at 1.12. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Deutsche Bank have made an estimate for Biohaven Ltd shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 11, 2025. While these analysts kept the previous recommendation, Jefferies raised their target price to Buy. The new note on the price target was released on September 16, 2024, representing the official price target for Biohaven Ltd stock. Previously, the target price had yet another raise to $55, while Bernstein analysts kept a Outperform rating on BHVN stock.
The Average True Range (ATR) for Biohaven Ltd is set at 2.19 The Price to Book ratio for the last quarter was 6.22, with the Price to Cash per share for the same quarter was set at 3.17.
BHVN stock trade performance evaluation
Biohaven Ltd [BHVN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -21.88. With this latest performance, BHVN shares dropped by -14.76% in over the last four-week period, additionally sinking by -69.83% over the last 6 months – not to mention a drop of -53.17% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BHVN stock in for the last two-week period is set at 32.02, with the RSI for the last a single of trading hit 26.66, and the three-weeks RSI is set at 34.35 for Biohaven Ltd [BHVN]. The present Moving Average for the last 50 days of trading for this stock 23.23, while it was recorded at 19.16 for the last single week of trading, and 37.49 for the last 200 days.
Biohaven Ltd [BHVN]: An insightful look at the core fundamentals
Biohaven Ltd’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.33 and a Current Ratio set at 2.33.
Earnings per share (EPS) analysis for Biohaven Ltd [BHVN] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BHVN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Biohaven Ltd go to 18.68%.
Biohaven Ltd [BHVN]: Institutional Ownership
The top three institutional holders of BHVN stocks are: VANGUARD GROUP INC with ownership of 7.27 million shares, which is approximately 8.2855%. STIFEL FINANCIAL CORP, holding 6.48 million shares of the stock with an approximate value of $$224.94 million in BHVN stocks shares; and STIFEL FINANCIAL CORP, currently with $$214.15 million in BHVN stock with ownership which is approximately 7.0298%.
